These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 32805201)

  • 1. Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis.
    Boucheron P; Lu Y; Yoshida K; Zhao T; Funk AL; Lunel-Fabiani F; Guingané A; Tuaillon E; van Holten J; Chou R; Bulterys M; Shimakawa Y
    Lancet Infect Dis; 2021 Jan; 21(1):85-96. PubMed ID: 32805201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of mother-to-child transmission of hepatitis B in relation to maternal peripartum antiviral prophylaxis: A systematic review and meta-analysis.
    Yao N; Fu S; Wu Y; Tian Z; Feng Y; Li J; Luo X; Yang Y; Ji F; Chen Y; Liu J; Zhao Y; Chen T
    Acta Obstet Gynecol Scand; 2022 Nov; 101(11):1197-1206. PubMed ID: 36082797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis.
    Funk AL; Lu Y; Yoshida K; Zhao T; Boucheron P; van Holten J; Chou R; Bulterys M; Shimakawa Y
    Lancet Infect Dis; 2021 Jan; 21(1):70-84. PubMed ID: 32805200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of HBV-DNA and HBeAg as antiviral therapeutic indicators among HBV-infected pregnant women: a systematic review and meta-analysis.
    Liu X; Chen C; Jiang D; Cui D; Yan D; Zhou Y; Ding C; Lan L; Huang C; Zhang X; Li L; Zhu C; Yang S
    Ann Palliat Med; 2021 Sep; 10(9):9362-9371. PubMed ID: 34379980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus.
    Lu Y; Song Y; Zhai X; Zhu F; Liu J; Chang Z; Li Y; Xiao Y; Li L; Liu M; Liu J; Duan Z; Zou H; Zhuang H; Wang J; Li J
    Emerg Microbes Infect; 2021 Dec; 10(1):555-564. PubMed ID: 33682609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial.
    Segeral O; Dim B; Durier C; Nhoueng S; Chhim K; Sovann S; Yom S; Vong C; Yin S; Ros B; Ky V; Pech S; Nem B; Hout K; Guillebaud J; Ear E; Caroupaye-Caroupin L; Rekacewicz C; Fernandez L; Laurent D; Yay C; Kim R; Meyer L; Chhun S;
    Lancet Infect Dis; 2022 Aug; 22(8):1181-1190. PubMed ID: 35643089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of hepatitis B immunoglobulin in prevention of mother-to-child transmission of chronic hepatitis B in HBsAg- and HBeAg-positive mother.
    Wang H; Fang JW; Gu ZW; Song DJ; Chen Y; Chen GD; Zhao B; Sun C; Ma Y; Wang KX; Shen JQ; Yang XF; Luo Q
    J Obstet Gynaecol; 2022 Jul; 42(5):877-882. PubMed ID: 34569426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
    Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
    BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cautionary note to hepatitis B e antigen (HBeAg)-negative test results in pregnant women in an area prevalent of HBeAg-negative chronic hepatitis B.
    Chalid MT; Turyadi ; Ie SI; Sjahril R; Wahyuni R; Nasrum Massi M; Muljono DH
    J Med Virol; 2023 Jan; 95(1):e28125. PubMed ID: 36064856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eliminating mother-to-child transmission of hepatitis B virus: practice and progress in Baoan, a national pilot district of China.
    Luo YL; Gao S; Zhang QF; Liu X; Lv DY; Chen JH; Wang W
    BMC Public Health; 2024 Jan; 24(1):58. PubMed ID: 38166939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with mother-to-child transmission of hepatitis B virus despite immunoprophylaxis.
    Liu CP; Zeng YL; Zhou M; Chen LL; Hu R; Wang L; Tang H
    Intern Med; 2015; 54(7):711-6. PubMed ID: 25832930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of vitamin D and polymorphisms of its receptor with antiviral therapy in pregnant women with hepatitis B.
    Wang R; Zhu X; Zhang X; Liu H; Ji YL; Chen YH
    World J Gastroenterol; 2023 May; 29(19):3003-3012. PubMed ID: 37274802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fulminant hepatitis B virus (HBV) infection in an infant following mother-to-child transmission of an e-minus HBV mutant: Time to relook at HBV prophylaxis in South African infants.
    Ogunbosi B; Smuts H; Eley B; Korsman S; De Lacy R; Hardie DR
    S Afr Med J; 2018 Apr; 108(5):389-392. PubMed ID: 29843851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of mother-to-child transmission of hepatitis B virus after fetal blood sampling: a report of six cases.
    Han Z; Zhang Y; Zhou J; Wang Q; Huang Y; Hou H
    BMC Infect Dis; 2021 Jul; 21(1):716. PubMed ID: 34330230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
    Yin YZ; Zhou J; Zhang PZ; Hou HY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course of 161 untreated and tenofovir-treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region.
    Samadi Kochaksaraei G; Castillo E; Osman M; Simmonds K; Scott AN; Oshiomogho JI; Lee SS; Myers RP; Martin SR; Coffin CS
    J Viral Hepat; 2016 Jan; 23(1):15-22. PubMed ID: 26192022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management Algorithm for Interrupting Mother-to-Child Transmission of Hepatitis B Virus.
    Hou J; Cui F; Ding Y; Dou X; Duan Z; Han G; Jia J; Mao Q; Li J; Li Z; Liu Z; Wei L; Xie Q; Yang X; Zhang H; Zhuang H
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):1929-1936.e1. PubMed ID: 30312789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of Mother-to-Child Hepatitis B Virus Prevention Program: Integration of Maternal Screening and Infant Post-Vaccination Serologic Testing.
    Su WJ; Chen HL; Chen SF; Liu YL; Wang TA; Ho YC; Chang MH
    Clin Infect Dis; 2024 Sep; 79(3):690-700. PubMed ID: 38562001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proportion of pregnant women with HBV infection eligible for antiviral prophylaxis to prevent vertical transmission: A systematic review and meta-analysis.
    Delamare H; Ishii-Rousseau JE; Rao A; Cresta M; Vincent JP; Ségéral O; Nayagam S; Shimakawa Y
    JHEP Rep; 2024 Aug; 6(8):101064. PubMed ID: 39035070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.